| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
|
Landoni, Giovanni
|
|
|
11 |
4 |
p. 1559-1574
|
article
|
| 2 |
Capacity Building in Sub-Saharan Africa as Part of the INTENSE-TBM Project During the COVID-19 Pandemic
|
Ariza-Vioque, E.
|
|
|
11 |
4 |
p. 1327-1341
|
article
|
| 3 |
Climate Change and Cascading Risks from Infectious Disease
|
Semenza, Jan C.
|
|
|
11 |
4 |
p. 1371-1390
|
article
|
| 4 |
Clinical Characteristics of Chlamydia psittaci Pneumonia Infection in Central South China
|
Yang, Min
|
|
|
11 |
4 |
p. 1631-1647
|
article
|
| 5 |
Combined Bacterial Meningitis and Infective Endocarditis: When Should We Search for the Other When Either One is Diagnosed?
|
Béraud, Guillaume
|
|
|
11 |
4 |
p. 1521-1540
|
article
|
| 6 |
Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
|
Yang, Joe
|
|
|
11 |
4 |
p. 1459-1460
|
article
|
| 7 |
Correction to: Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection
|
Fodor, Eszter
|
|
|
11 |
4 |
p. 1767-1768
|
article
|
| 8 |
Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
|
Yang, Joe
|
|
|
11 |
4 |
p. 1443-1457
|
article
|
| 9 |
Cost-Effectiveness of Newly Recommended Pneumococcal Vaccination Strategies in Older Underserved Minority Adults in the USA
|
Smith, Kenneth J.
|
|
|
11 |
4 |
p. 1683-1693
|
article
|
| 10 |
Does Monitoring Total and Free Polymyxin B1 Plasma Concentrations Predict Polymyxin B-Induced Nephrotoxicity? A Retrospective Study in Critically Ill Patients
|
Deng, Yang
|
|
|
11 |
4 |
p. 1591-1608
|
article
|
| 11 |
Drug Resistance and Risk Factors for Acquisition of Gram-Negative Bacteria and Carbapenem-Resistant Organisms Among Liver Transplant Recipients
|
Wu, Xiaoxia
|
|
|
11 |
4 |
p. 1461-1477
|
article
|
| 12 |
Durability and Immunogenicity of Neutralizing Antibodies Response Against Omicron Variants After Three Doses of Subunit SARS-CoV-2 Vaccine MVC-COV1901: An Extension to an Open-Label, Dose-Escalation Phase 1 Study
|
Hsieh, Szu-Min
|
|
|
11 |
4 |
p. 1493-1504
|
article
|
| 13 |
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study
|
Babich, Tanya
|
|
|
11 |
4 |
p. 1505-1519
|
article
|
| 14 |
Effectiveness and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir as a Hepatitis C Virus Infection Salvage Therapy in the Real World: A Systematic Review and Meta-analysis
|
Xie, Jing
|
|
|
11 |
4 |
p. 1661-1682
|
article
|
| 15 |
Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China
|
Zhou, Yihong
|
|
|
11 |
4 |
p. 1575-1590
|
article
|
| 16 |
Eliminate Hepatitis C as a Public Health Threat: A Narrative Review of Strategies, Gaps, and Opportunities for China
|
Song, Yuanyuan
|
|
|
11 |
4 |
p. 1427-1442
|
article
|
| 17 |
Explainable Machine-Learning Model for Prediction of In-Hospital Mortality in Septic Patients Requiring Intensive Care Unit Readmission
|
Hu, Chang
|
|
|
11 |
4 |
p. 1695-1713
|
article
|
| 18 |
Genomic Epidemiology of MBL-Producing Pseudomonas putida Group Isolates in Poland
|
Urbanowicz, Paweł
|
|
|
11 |
4 |
p. 1725-1740
|
article
|
| 19 |
Immune Response to COVID-19 and mRNA Vaccination in Immunocompromised Individuals: A Narrative Review
|
Napuri, Norka I.
|
|
|
11 |
4 |
p. 1391-1414
|
article
|
| 20 |
Integrase Inhibitors Partially Restore Bacterial Translocation, Inflammation and Gut Permeability Induced by HIV Infection: Impact on Gut Microbiota
|
Villoslada-Blanco, Pablo
|
|
|
11 |
4 |
p. 1541-1557
|
article
|
| 21 |
Laparoscopic Treatment Strategies for Liver Echinococcosis
|
Wan, Li
|
|
|
11 |
4 |
p. 1415-1426
|
article
|
| 22 |
Letter to the Editor Regarding: “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants”
|
Gomez, Jorge A.
|
|
|
11 |
4 |
p. 1757-1761
|
article
|
| 23 |
Linezolid vs Vancomycin in Induced Thrombocytopenia
|
Al-Harbi, Dimah
|
|
|
11 |
4 |
p. 1649-1660
|
article
|
| 24 |
Meningococcal Disease and Immunization Activities in Hajj and Umrah Pilgrimage: a review
|
Badur, Selim
|
|
|
11 |
4 |
p. 1343-1369
|
article
|
| 25 |
Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections
|
Ostrosky-Zeichner, L.
|
|
|
11 |
4 |
p. 1609-1629
|
article
|
| 26 |
Perspectives on the Ethics of Antibiotic Overuse and on the Implementation of (New) Antibiotics
|
Hays, John P.
|
|
|
11 |
4 |
p. 1315-1326
|
article
|
| 27 |
Post-Marketing Surveillance of Tetravalent Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus (DTaP-IPV) Vaccine in South Korea, 2009 to 2015
|
Choe, Young June
|
|
|
11 |
4 |
p. 1479-1492
|
article
|
| 28 |
Potential of Continuous Local Antibiotic Perfusion Therapy for Fracture-Related Infections
|
Kosugi, Kenji
|
|
|
11 |
4 |
p. 1741-1755
|
article
|
| 29 |
Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens
|
Morrisette, Taylor
|
|
|
11 |
4 |
p. 1715-1723
|
article
|
| 30 |
Response to Gomez et al.’s Letter to the Editor Regarding: “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants”
|
Perdrizet, Johnna
|
|
|
11 |
4 |
p. 1763-1765
|
article
|
Journal description